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Many human tumors contain high concentrations of ethanolamine phosphate (EtnP). An important question is whether increased formation of 
EtnP is merely the consequence of cell transformation, or is it associated with the process of carcinogenesis. Here we show that in C,I-I/lOTlR 
embryonic fibroblasts, an established cellular model for the study of carcinogenesis, the environmental carcinogens, 7,12dimethylbenz[a]anthracene 
(DMBA) and benzo[a]pyrene (B[a]P) (0.1-l &ml concentration; 24 h treatment), stimulate phosphorylation of ethanolamine derived from 
increased hydrolysis of phosphatidylethanolamine. The results suggest hat increased formation of EtnP is associated with the early stages of 
carcinogenesis. This observation may have prognostic value. 
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1. INTRODUCTION 
It is now well established that most human tumors 
contain high concentrations of phosphomonoesters, in- 
cluding ethanolamine phosphate (EtnP) and choline 
phosphate (Chop) [l-8]. Interestingly, in several differ- 
ent types of tumors the major phosphomonoester has 
been identified as EtnP [g-14]. These studies raise the 
following important questions: (i) what mechanism(s) is 
(are) responsible for the increased levels of phospho- 
monoesters in cancer cells?; (ii) is increased formation 
of phosphomonoesters merely the consequence of cell 
transformation, or is this process associated with, or 
does it perhaps contribute to, the transformation proc- 
ess?; (iii) what is the mechanism of selective enhance- 
ment of EtnP in the respective cancer cells? 
for 24 h enhanced the formation of EtnP, but not Chop. 
The results presented here indicate that this carcinogen 
effect is due, in part, to increased activity of an etha- 
nolamine (Etn) kinase. Two different Etn pools, derived 
from the external medium and from phosphatidyletha- 




DMBA, B[a]P, and Dowex-SOW (H+ form) were purchased from 
Sigma; [2-‘4C]ethanolamine (50 mCi/mmol) and [methyl-‘4C]choline 
were brought from Amersham; tissue culture reagents were from 
Gibco BRL. 
2.2. Cell culture 
The embryonic C,H/lOTl/:! fibroblast line is a well- 
established model system for the study of chemical 
carcinogenesis [15-171. Our hypothesis has been that if 
increased formation of phosphomonoesters i  associ- 
ated with the process of cell transformation, then in this 
cell line carcinogens should enhance the cellular level 
of EtnP and/or Chop at a relatively early stage of treat- 
ment. Here we show that treatment of these fibroblasts 
with the environmental carcinogens, 7,1Zdimethyl- 
benz[a]anthracene (DMBA) or benzo[a]pyrene (B[a]P), 
The C,H/lOTl/2 embryonal fibroblast line was from American 
Type Culture Collection. Fibroblast cultures were maintained in basal 
Eagle’s medium supplemented with 10% fetal calf serum (heat-inac- 
tivated). Cells were used between passages 10-15. 
2.3. Determination of EtnP formation andphospholipase-mediated hy- 
drolysis of PtdEtn in fibroblasts 
C,WlOTlR fibroblasts were grown in 6-well culture dishes for 
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48 h (up to _ 80% confluency) in the presence of [?Z]Etn (1 .O fiCi/ml). 
In the experiment shown in Fig. 1, carcinogens were present during 
the last 24 h of the labeling period at concentrations indicated in the 
figure legend. For the determination of cellular content of [14C]Etn 
metabolites, cells were washed twice with 5 ml medium followed by 
the addition of ice-cold methanol (2 ml) to the wells, and by rapid 
transfer of methanol extracts to tubes containing chloroform. After 
phase separation, the water-soluble derivatives of [?Z]Etn were sepa- 
rated on Dowex-SO[H+] columns as previously described [18]. [“YJEtn 
and its metabolites were identified by thin-layer chromatography [19]. 
PtdEtn was separated from other phospholipids as previously indi- 
cated [19]. 
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For the determination of PLD- and PLC-mediated hydrolysis of 
PtdEtn, fibroblasts were labeled with [r4C]ethanolamine as above but 
the carcinogens were added for the last 20 h of the labeling period. 
Cells were washed and then incubated in fresh medium for 4 h (to 
decrease the background levels of water-soluble [“‘C]Etn products; see 
[20]) in the absence or presence of carcinogens. Cells were washed 
again, and then incubated for 3G120 min in 1 .O ml medium containing 
2 mM unlabeled Etn. We have established earlier that in fibroblasts 
unlabeled Etn can effectively block metabolism of newly formed 
[14C]Etn [20,21] and [?Z]EtnP [18], and that [‘4C]PtdEtn is the com- 
mon precursor for newly formed [14C]Etn and [14C]EtnP (formed by 
PLD- and PLC-mediated mechanisms, respectively). Ice-cold metha- 
nol (2 ml) was added to the wells (without removing the medium), and 
[14C]Etn and [14C]EtnP were determined as described above. 
A_ T T 
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2.4. Determination ofcellular uptake andphosphorylation f [“C]Etn 
in fibroblasts 
C,H/lOTlR fibroblasts, grown in 6-well tissue culture dishes up to 
- 80% confluency, were treated with B[a]P (0.5 &ml) or 
DMBA (0.5 &ml) for 24 h, followed by incubation of cells in the 
presence of [2-14C]Etn (810,000 dpm/well) for 3&120 min. Cells were 
washed (for 15 s) twice with 5 ml medium, followed by the addition 
of 2 ml ice-cold methanol. Water-soluble [“‘C]Etn metabolites and 
[14C]PtdEtn were separated as described above. 
3. RESULTS AND DISCUSSION 
When cells are labeled with [i4C]Etn for an extended 
time period (presently for 48 h), the different metabolic 
pools of [14C]PtdEtn derivatives are in near isotopic 
equilibrium. As a consequence, changes in the 14C con- 
tent of various Etn-containing compounds will reflect 
proportional changes in their mass. This radiolabeling 
method is sensitive and is also suitable for the determi- 
nation of the mechanisms involved in the metabolism of 
Etn-containing compounds. Therefore, in the present 
study, we used mostly [14C]Etn-labeled fibroblasts to 
determine possible effects of carcinogens on the cellular 
levels of PtdEtn and its water-soluble metabolites. 
Fig. 1. Effects of carcinogens on the cellular content of [14C]PtdEtn, 
[14C]EtnP and [14C]Etn in C,H/lOT1/2 fibroblasts. Fibroblasts, grown 
in 6-well culture dishes, were labeled with [14C]Etn for 48 h. Carcino- 
gen was not present (o), or B[a]P (I) or DMBA (II) was added to 
fibroblasts at the concentrations of 0.1 pg/ml (o), 0.5 @ml (o), or 
1 pg/ml (m) for the last 24 h of the labeling period. The cellular content 
of [‘4C]PtdEtn (A), [r4CJEtnP (B), and [14C]Etn (C)was determined as 
described in section 2. Data are the mean + S.E.M. of three experi- 
ments each performed in triplicate. *~**Significantly (P c 0.05*- 
0.01**) different from the respective control (Student’s t-test). 
Chronic (24 h) treatment of [14C]Etn-labeled fibro- 
blasts with either B[a]P or DMBA decreased the cellular 
level of [i4C]PtdEtn. A detectable decrease (S-10%) in 
[14C]PtdEtn content was elicited by 0.1 pg/rnl concentra- 
tion of carcinogens (a suboptimal concentration with 
respect to carcinogenesis; [15]), while maximal effects 
(17 and 20% decrease) required a 1 pg/ml concentration 
of B[a]P and DMBA, respectively (Fig. 1A). In order to 
verify that the observed reduction in cellular [14C]Ptd- 
Etn indeed corresponded to reduced phospholipid 
mass, we next determined the P, content of PtdEtn in 
fibroblasts treated with 0.5 &ml of DMBA for 24 h. 
In these experiments pecial care was taken to minimize 
errors which could result from slight differences in the 
initial cell number. Therefore, DMBA was added to 
fibroblasts at -75% confluency, so that at the time of 
harvest the fibroblast cultures were in the confluent 
state (i.e. in each 150~mm dish, the cell number was the 
same). In agreement with our expectation, DMBA re- 
duced the Pi content of PtdEtn from 2.35 rf: 0.16 &dish 
(n = 8) to 1.86 + 0.14 ,ug/dish (n = 8). 
cellular [14C]PtdEtn level was accompanied by a pro- 
nounced increase in the cellular level of [14C]EtnP (Fig. 
1B) and by a moderate elevation in the cellular content 
of [14C]Etn (Fig. 1C). In contrast, these carcinogens 
failed to enhance the formation of glycerophosphoetha- 
nolamine (data not shown). Treatment of fibroblasts 
with either carcinogen (1 &ml) for only 4 h did not 
elicit statistically significant changes in the cellular level 
of any of the above Etn-containing compounds. 
Similar experiments were performed with [‘“Cl- 
choline-labeled fibroblasts. While carcinogens (1 &nl; 
24 h treatment) decreased the cellular content of 
[14C]PtdCho about 8-lo%, we have not observed corre- 
sponding increases in the cellular levels of [i4C]choline 
and/or [i4C]ChoP (data not shown). This would be con- 
sistent with increased PLD-mediated degradation of 
PtdCho in carcinogen-treated fibroblasts, followed by 
the et&ix of newly formed [‘4C]choline. Experiments are 
presently underway in our laboratory to address this 
and other possibilities. 
In each case, the carcinogen-induced ecrease in the Carcinogen-induced increase in the cellular levels of 
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Fig. 2. Effects of carcinogens on the uptake and metabolism of 
[‘%]Etn in C,WlOTlR fibroblasts. Fibroblasts, grown in 6-well cul- 
ture dishes, were untreated (o), or were treated with OS&ml of B[a]P 
(A) or 0.5 ,~g/ml of DMBA (u) for 24 h, followed by incubation of 
fibroblasts in the presence of [%]Etn (810,000 dpm/well) for up to 
120 min. Incorporation of exogenous [14C]Etn into the cellular pools 
of PtdEtn (A), Etn (B), and EtnP (C) were determined as described 
in section 2. Each point represents the mean + S.E.M. of three experi- 
ments each performed in quadruplicate. 
[14C]EtnP and [14C]Etn could reflect an inhibition of 
PtdEtn synthesis, but also could be due to increased 
hydrolysis of [14C]PtdEtn. Alternatively, carcinogens 
could enhance cellular uptake and/or phosphorylation 
of [14C]ethanolamine. To distinguish among these, not 
necessarily exclusive, mechanisms, we next examined 
the effects of carcinogens on the cellular uptake and 
phosphorylation of [14C]Etn, as well as on the synthesis 
of PtdEtn from this precursor. Pretreatment of fibro- 
blasts with 0.5 ,@ml of B[a]P or DMBA for 24 h re- 
sulted in enhanced labeling of PtdEtn with [14C]Etn dur- 
ing a subsequent labeling period (Fig. 2A). At each time 
interval (30-120 min) of the labeling period examined, 
B[a]P and DMBA stimulated incorporation of [14C]Etn 
into PtdEtn 1.3-to 1.5-fold and 1.4-to 1.6-fold,respec- 
tively. During the same incubation period, carcinogen- 
pretreated cells accumulated somewhat less [14C]Etn 
(Fig. 2B), but they formed significantly more [14C]EtnP 
than control cells (Fig. 2C). In each case, the carcino- 
gen-induced increase in [14C]EtnP formation corre- 
sponded to the formation of [14C]PtdEtn. These experi- 
ments established that carcinogens do not inhibit 
PtdEtn synthesis. Also, the results made it clear that 
under the present conditions [14C]EtnP could not possi- 
bly be formed from [14C]PtdEtn, because the 14C content 
of this latter compound was too small to serve as a 
precursor. Finally, since carcinogens decreased, rather 
than enhanced, the cellular level of [14C]Etn, it appeared 
that the stimulatory effects of carcinogens on the cellu- 
lar content of [14C]EtnP were due to increased phospho- 
rylation of [14C]Etn, followed by a compensatory in- 
crease in the cellular uptake of [14C]Etn. 
While the above experiments indicated that carcino- 
gens can enhance the formation of EtnP by a mecha- 
nism which is independent of PtdEtn hydrolysis, the 
question whether the observed carcinogen-induced loss 
of PtdEtn (Fig. 1A) and increase in cellular EtnP level 
(Fig. 1B) were causally related processes or not re- 
mained to be established. To clarify this issue, we next 
determined the effects of carcinogens on PLC- and 
PLD-mediated hydrolysis of PtdEtn. As shown in 
Table I, treatment of [14C]Etn-labeled fibroblasts with 
carcinogens for 2 h failed to enhance the formation of 
[14C]EtnP from the cellular [14C]PtdEtn substrate pool. 
In contrast, treatments of labeled fibroblasts with B[a]P 
(0.5 ,~g!ml) or DMBA (0.5 @ml) similarly enhanced 
the formation of [14C]Etn from [14C]PtdEtn$Fig. 3). We 
should emphasize here that addition of 2 mM Etn to the 
incubation medium prevented metabolism of newly 
formed [14C]Etn and [14C]EtnP [l&20,21]. For this rea- 
son, and because there was an inverse relationship be- 
tween carcinogen-induced formation of [14C]Etn and 
the loss of cellular [14C]PtdEtn (data not shown), forma- 
tion of [14C]Etn most probably occurred by PLD-medi- 
ated hydrolysis of [14C]PtdEtn. On the other hand, when 
the above experiment (Fig. 3) was repeated so that the 
incubation medium did not contain unlabeled Etn, 
about 95% of [14C]PtdEtn-derived water-soluble 14C ac- 
tivity was present in EtnP. Thus, under normal condi- 
tions (i.e. in the absence of unlabeled Etn), PtdEtn hy- 
Table I 
Effects of carcinogens on the formation of [“‘C]EtnP from the pre- 
labeled cellular pool of [‘%]PtdEtn in C,H/lOTl/Z fibroblasts 
Treatment with Formation of [‘%]EtnP 
(dpm/106 dpm of [‘%]PtdEtn/2 h) 
None 
B[alP 
43,060 f 2,940 
45,180 + 4,410 
DMBA 37,720 + 3,780 
Fibroblasts, grown in 6-well culture dishes, were labeled with [‘%]Etn 
for 48 h and then treated with 0.5 pg./ml of B[a]P or DMBA for the 
last 20 h of the labeling period, as indicated. Fibroblasts were washed 
and then incubated for 4 h in fresh medium in the absence or presence 
of carcinogens (0.5 &ml), as appropriate. Fibroblasts were washed 
again and then incubated for 2 h in fresh medium (containing 2 mM 
unlabeled Etn) to determine formation of [“‘C]EtnP. Data are the 
mean + S.E.M. of two experiments each performed in triplicate. 
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Fig. 3. Effects of carcinogens on the formation of [‘%]Etn from the 
pre-labeled cellular pool of [%]PtdEtn in C,H/lOT1/2 fibroblasts. 
Fibroblasts, grown in 6-well culture dishes and labeled with [14C]Etn 
for 48 h, were untreated (0) or were treated with 0.5 &ml of B[a]P 
(A) or 0.5 &ml of DMBA (w) for the last 20 h of the labeling period. 
Fibroblasts were washed and then incubated for 4 h in fresh medium 
in the absence or presence of carcinogens (0.5 &ml) as appropriate. 
Fibroblasts were washed again, and then incubated for up to 120 min 
in fresh medium (containing 2 mM unlabeled Etn) to determine forma- 
tion of [‘%]Etn. Each point represents the mean f S.E.M. of three 
experiments, each performed in triplicate. 
drolysis in carcinogen-treated cells yields practically 
only EtnP. 
In other experiments, carcinogen-induced formation 
of [14C]Etn from [14C]PtdEtn was not affected by l- 
10 mM choline or 1-serine, which argues against stimu- 
lation of a base-exchange mechanism by carcinogens. 
However, further experiments are required to definitely 
prove activation of PLD in carcinogen-treated cells. 
In summary, the results presented here show that in 
embryonic fibroblasts carcinogens timulate the forma- 
tion of EtnP well before transformation of fibroblasts 
occurs. Stimulation of an Etn kinase activity appears to 
play a key role in this process. Since blood Etn levels are 
low [22], it is reasonable to assume that PtdEtn-derived 
Etn also serves as a substrate for Etn kinase. These data 
raise the possibility that determination of EtnP levels 
may help to better identify the early stages of carcino- 
genesis. Further experiments are required to clarify 
whether the presently observed changes in the cellular 
levels of EtnP and PtdEtn play a role in carcinogenesis. 
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